Insider Transactions last 24 months for Intellia Therapeutics, Inc.  -  NSDQ: NTLA

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Clark ElianaEVP, Chief Technical Officer03/02/2026DSDirectCOM607$13.78$8,364.4693,864
Basta JamesEVP, General Counsel03/02/2026DSDirectCOM1,211$13.78$16,687.58156,794
Dube Michael PVP, Chief Accounting Officer03/01/2026AADirectCOM17,250$0.00$0.0069,527
Clark ElianaEVP, Chief Technical Officer03/01/2026AADirectCOM7,353$0.00$0.0094,471
Schultes Birgit CEVP, Chief Scientific Officer03/01/2026AADirectCOM39,200$0.00$0.00137,733
Dulac Edward J IiiEVP, Chief Financial Officer03/01/2026AADirectCOM61,280$0.00$0.00160,963
Lebwohl DavidEVP, Chief Medical Officer03/01/2026AADirectCOM9,943$0.00$0.00131,192
Basta JamesEVP, General Counsel03/01/2026AADirectCOM46,080$0.00$0.00158,005
Leonard John MPresident and CEO03/01/2026AADirectCOM156,400$0.00$0.001,169,739
Dube Michael PVP, Chief Accounting Officer01/05/2026DSDirectCOM2,989$9.21$27,528.6952,277
Dulac Edward J IiiEVP, Chief Financial Officer01/05/2026DSDirectCOM6,379$9.21$58,750.5999,683
Clark ElianaEVP, Chief Technical Officer01/05/2026DSDirectCOM9,515$9.21$87,633.1587,118
Lebwohl DavidEVP, Chief Medical Officer01/05/2026DSDirectCOM11,903$9.21$109,626.63121,249
Cohen Fred EDirector01/05/2026APDirectCOM150,000$9.35$1,402,500.00207,453
Basta JamesEVP, General Counsel01/05/2026DSDirectCOM10,397$9.21$95,756.37101,528
Schultes Birgit CEVP, Chief Scientific Officer01/05/2026DSDirectCOM8,508$9.21$78,358.6898,533
Leonard John MPresident and CEO01/05/2026DSDirectCOM34,146$9.21$314,484.661,013,339
Leonard John MPresident and CEO12/12/2025AMDirectCOM8,557$6.83$58,444.311,047,485
Leonard John MPresident and CEO12/11/2025DSDirectCOM5,355$9.59$51,354.451,038,928
Leonard John MPresident and CEO12/11/2025DSDirectCOM32,832$9.47$310,919.041,044,283
Leonard John MPresident and CEO12/11/2025DSDirectCOM49,959$9.49$474,110.911,077,115
Leonard John MPresident and CEO12/11/2025AMDirectCOM49,959$6.83$341,219.971,127,074
Dube Michael PVP, Chief Accounting Officer10/01/2025DSDirectCOM1,871$17.38$32,517.9855,266
Schultes Birgit CEVP, Chief Scientific Officer10/01/2025DSDirectCOM31$17.38$538.78105,184
Chase William JDirector08/20/2025APDirectCOM100,000$10.03$1,003,000.00134,693
1   2  3  Next Last  You are at page 1 of 3 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel